Pierre Daudé1,2, Thomas Troalen3, Adèle L C Mackowiak4,5,6, Emilien Royer1,2, Davide Piccini4,7, Jérôme Yerly4,8, Josef Pfeuffer9, Frank Kober1,2, Sylviane Confort Gouny1,2, Monique Bernard1,2, Matthias Stuber4,8, Jessica A M Bastiaansen5,6, and Stanislas Rapacchi1,2
1Aix-Marseille Univ, CNRS, CRMBM, Marseille, France, 2APHM, Hôpital Universitaire Timone, CEMEREM, Marseille, France, 3Siemens Healthcare SAS, Saint-Denis, France, 4Department of Diagnostic and Interventional Radiology, Lausanne University Hospital, Lausanne, Switzerland, 5Department of Diagnostic, Interventional and Pediatric Radiology (DIPR), Inselspital, Bern University Hospital, University of Bern, Bern, Switzerland, 6Translation Imaging Center (TIC), Swiss Institute for Tranlational and Entrepreneurial Medicine, Bern, Switzerland, 7Advanced Clinical Imaging Technology, Siemens Healthineers International AG, Lausanne, Switzerland, 8Center for Biomedical Imaging, Lausanne, Switzerland, 9Siemens Healthcare, MR Application Development, Erlangen, Germany
Synopsis
Keywords: Fat, Quantitative Imaging
Free-running cardiac Dixon-MRI has the potential for motion-resolved R
2*
and PDFF quantification to explore cardiac fat accumulation and alteration in
metabolic diseases. This study combines a self-navigated 3D radial sequence
with 13 echoes using fast bipolar signal-readouts, a k-space trajectory
correction, a compressed sensing reconstruction, and IDEAL fat-water separation
to obtain precise ( limits of agreement: ±1.2 % and 5.0 s
-1)
and highly spatially and motion-resolved quantitative PDFF and R
2*
maps of the whole heart. We report here the first in vivo characterization of metabolically-active
epicardial fat (PDFF: 81.6±9.6 %),
distinct from adjacent paracardial fat.
Introduction
There is a growing interest to
better understand the pathophysiological role of cardiac fat towards cardiovascular
degradation in metabolic diseases1. As epicardial adipose tissue(EAT) can become an inflammatory substrate
under pathological conditions, emerging therapies are aiming at modulating its
metabolic functions2. However, there is a lack of non-invasive
tools that can probe EAT, which is thin and moves with cardiac and respiratory
motion. Dixon-MRI enables high resolution mapping of proton density
fat-fraction (PDFF) and R2*, two non-invasive biomarkers3 that hold potential to differentiate the metabolic
status of EAT4. Nevertheless, cardiac Dixon-MRI remains challenging
due to the concomitant need for high spatial and temporal (rapid water/fat
phase accrual) resolution and robust motion compensation. To overcome those
hurdles, the free-running framework5 is a promising approach that enables high spatial-resolution
cardiac imaging with fully respiratory and cardiac self-gating, combined with a
multidimensional compressed sensing reconstruction. Using the full potential of
a custom-built free-running multi-echo sequence and a dedicated Dixon framework6, cardiac adipose tissue was investigated in healthy
population and two diabetic patients.Methods
A research 3D radial spoiled gradient echo
sequence was implemented with multiple echoes and a phyllotaxis trajectory for
integration with the free-running framework5(Fig1).
Data were acquired on a 3T scanner (MAGNETOM Vida, Siemens Healthcare,
Erlangen, Germany).
A ten minute acquisition, with a TR
of 15ms and 13 echoes (TE1/ΔTE=1.12/1.07ms) using fast bipolar readouts and 40014 radial views per
echo segmented in 3078 segments of 13 lines each was acquired with FOV=(220mm)3
at isotropic 1.5mm resolution with FA=5° and BW=1510 Hz/px.
To compensate for gradients
imperfections and delays (which get worse with bipolar readouts), a k-space
trajectory correction was applied using the system-specific Gradient system
Impulse Response Function (GIRF)7,8. Cardiac and respiratory motion gating signals
were extracted from the first echo of the superior-inferior projections. The 6D
k-space data (R=26x acceleration) were binned in 4 respiratory phases and
100ms-wide cardiac phases and then were reconstructed using the free-running
compressed sensing framework(5).
Complex images were processed for fat-water separation using the Iterative
Decomposition of water and fat with Echo Asymmetry and Least square Estimation
(IDEAL) method with constrained extension9,10. Precision of the quantitative
parameters (PDFF, R2*). was evaluated numerically by simulated synthetic Dixon-MRI
(TE1/ΔTE=1.12/1.07ms, NTE=13)
with the full range of PDFF(0:1:100) and a large range of B0 off-resonance(-200:4:200
Hz) at SNR=10, 50. Cardiac adipose tissue (epicardial and paracardial fat (PAT)) and
subcutaneous fat(SAT) were segmented at the apex and the abdomen respectively at TE1 along
the fully respiration and cardiac cycle and explored on 11 healthy subjects (38±14 y.o.
; BMI: 23.0±1.6 kg/m2 ; 2 women) and two diabetic patients (63±3 y.o. ; BMI: 28.3±13.8
kg/m2 ; 2 women).Results
Numerical simulations demonstrated
that PDFF and R2* quantification with a SNR=50 were
accurate with a mean PDFF and R2* bias less than 0.05% and 0.05 s-1
respectively and precise with limits of
agreement of ±1.2 % and 5.0 s-1 (Fig2). B0 maps confirmed a range within ±200 Hz
in the heart.
In the healthy
population, epicardial fat had a significantly lower fat fraction than the
subcutaneous fat (PDFF EAT=81.6±9.6% vs PDFF SAT=92.7±4.2%, P<0.001)(Fig3). Although
only present in three healthy volunteers and the diabetic patients,
paracardial fat PDFF (90.6±3.7%) tended to be superior to EAT PDFF.
The preliminary results in the type-2 diabetic patients suggested that
EAT fat fraction was also lower (86.4±5.0%) compared to either subcutaneous fat
(96.3±3.1%) or paracardial fat (92.5±2.9%) (Fig4).Discussion
Aiming for a precise high-resolution quantitative imaging of cardiac
adipose tissue, a 10 minute free-running cardiac Dixon acquisition provided whole
organ coverage with a 1.5 mm isotropic resolution. The method could separate
PDFF values between epicardial fat and other surrounding fats.
Preliminary results suggested a PDFF difference between EAT and other
adipose tissues (SAT and PAT when present) within the order of 5 to 10%. To
properly distinguish and probe EAT, the need for a precise mapping technique
becomes apparent. From numerical simulations and in vivo results,
proposed free-running cardiac Dixon acquisition showed to fit this need. Moreover,
the availability of full cardiac and respiratory cycles(Fig5) for cardiac fat quantification offers the
possibility to probe EAT in the most suitable cardiac and respiratory phases,
which are typically at end-expiration and peak-systole during which the
pericardium is thicker. Quantitative PDFF for characterizing EAT (PDFF EAT=81.6±9.6% in healthy population), may
be capable to probe the ‘colour’ of adipose tissue (brown, beige or white) as
brown fat has been shown to have a lower PDFF than white fat like SAT. A
larger cohort of healthy subjects and patients with metabolic disorders may
enable the identification of healthy and pathological PDFF ranges.
Due to
the proximity of the lungs, the B0 inhomogeneities field map had
large spatial variations, influencing R2* quantification (Fig4,Fig5). It would be of interest to integrate a priori information of the
scanner magnetic field distribution11,12 to improve
the robustness of the B0 field map estimation and correct the R2*
quantification13. Further investigation leveraging the
13 echoes could also provide valuable fatty acids composition characterization.Conclusion
This study demonstrated precise and highly-resolved
PDFF and R2* 3D maps to
probe cardiac fat in metabolic diseases, which was enabled thanks to free-running
cardiac Dixon-MRI GIRF corrected at 3T.Acknowledgements
This project has received financial support
from the CNRS through a MITI program and was performed within a laboratory
member of France Life Imaging network. (grant ANR-11-INBS-0006)References
1. Gaborit, B.; Sengenes, C.; Ancel, P.;
Jacquier, A.; Dutour, A. Role of Epicardial Adipose Tissue in Health and
Disease: A Matter of Fat? In Comprehensive Physiology; Terjung, R., Ed.;
John Wiley & Sons, Inc.: Hoboken, NJ, USA, 2017; pp. 1051–1082 ISBN
978-0-470-65071-4.
2. Doukbi,
E.; Soghomonian, A.; Sengenès, C.; Ahmed, S.; Ancel, P.; Dutour, A.; Gaborit,
B. Browning Epicardial Adipose Tissue: Friend or Foe? Cells 2022,
11, 991, doi:10.3390/cells11060991.
3. Reeder,
S.B.; Hu, H.H.; Sirlin, C.B. Proton Density Fat-Fraction: A Standardized
Mr-Based Biomarker of Tissue Fat Concentration. J. Magn. Reson. Imaging 2012,
36, 1011–1014, doi:10.1002/jmri.23741.
4. Wu,
M.; Junker, D.; Branca, R.T.; Karampinos, D.C. Magnetic Resonance Imaging
Techniques for Brown Adipose Tissue Detection. Front. Endocrinol. 2020,
11, 421, doi:10.3389/fendo.2020.00421.
5. Di
Sopra, L.; Piccini, D.; Coppo, S.; Stuber, M.; Yerly, J. An Automated Approach
to Fully Self‐gated Free‐running Cardiac and Respiratory Motion‐resolved 5D
Whole‐heart MRI. Magn. Reson. Med. 2019, 82, 2118–2132,
doi:10.1002/mrm.27898.
6. Daudé,
P.; Troalen, T.; Mackowiak, A.L.C.; Piccini, D.; Yerly, J.; Pfeuffer, J.;
Kober, F.; Confort Gouny, S.; Bernard, M.; Stuber, M.; et al. Trajectory
Correction Enables Free Running Cardiac DIXON at 3T.; London, UK, May 7 2022; p.
Poster.
7. Campbell-Washburn,
A.E.; Xue, H.; Lederman, R.J.; Faranesh, A.Z.; Hansen, M.S. Real-Time
Distortion Correction of Spiral and Echo Planar Images Using the Gradient
System Impulse Response Function: Real-Time Distortion Correction Framework for
Fast Imaging. Magn. Reson. Med. 2016, 75, 2278–2285,
doi:10.1002/mrm.25788.
8. Berzl,M.,Pfeuffer,J.
et al. Improved Spiral Trajectory Correction Using the Gradient Impulse
Response Function (GIRF). ISMRM 2017933.
9. Bydder,
M.; Ghodrati, V.; Gao, Y.; Robson, M.D.; Yang, Y.; Hu, P. Constraints in
Estimating the Proton Density Fat Fraction. Magn. Reson. Imaging 2020,
66, 1–8, doi:10.1016/j.mri.2019.11.009.
10. Daudé,
P.; Kober, F.; Confort Gouny, S.; Bernard, M.; Rapacchi, S. Comparative Review
of Algorithms and Methods for Proton-Density Fat Fraction (PDFF)
Quantification.; London, UK, May 7 2022; p. Oral.
11. Sharma,
S.D.; Artz, N.S.; Hernando, D.; Horng, D.E.; Reeder, S.B. Improving Chemical
Shift Encoded Water–Fat Separation Using Object-Based Information of the
Magnetic Field Inhomogeneity. Magn. Reson. Med. 2015, 73,
597–604, doi:10.1002/mrm.25163.
12. Diefenbach,
M.N.; Ruschke, S.; Eggers, H.; Meineke, J.; Rummeny, E.J.; Karampinos, D.C.
Improving Chemical Shift Encoding-Based Water-Fat Separation Based on a
Detailed Consideration of Magnetic Field Contributions. Magn. Reson. Med.
2018, 80, 990–1004, doi:10.1002/mrm.27097.
13. Hernando,
D.; Vigen, K.K.; Shimakawa, A.; Reeder, S.B. R2* Mapping in the Presence of
Macroscopic B0 Field Variations. Magn. Reson. Med. 2012, 68,
830–840, doi:10.1002/mrm.23306.
14. Mackowiak,
A.L.C.; Roy, C.W.; Yerly, J.; Falcão, M.B.L.; Bacher, M.; Speier, P.; Piccini,
D.; Stuber, M.; Bastiaansen, J.A.M. Whole-Heart Motion-Resolved Multi-Peak
Fat-Fraction Mapping Using Free-Running 3d Radial Multi-Echo Gre and Pilot
Tone. 2022, doi:10.48550/ARXIV.2210.06127.